ArticleBioengineering (Basel, Switzerland)2026
TPA-ConvNeXt: Trigonometric Phase Attention for Robust Retinal Disease Classification Across Fundus and OCT.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study proposes TPA-ConvNeXt, a ConvNeXt-Small-based deep learning architecture for retinal image classification using a phase-based trigonometric attention mechanism. The proposed Trigonometric Phase Attention (TPA) block recalibrates feature maps through learnable phase and amplitude modulation derived from channel-wise and spatial context. In addition, a stable fine-tuning strategy combining layer-wise learning rate decay (LLRD), linear warmup, and cosine annealing is employed to adapt pretrained backbones to medical image data. The method was evaluated on both fundus and optical coherence tomography (OCT) datasets. On the HYAMD fundus dataset, 5-fold cross-validation yielded a mean Macro F1 of 0.8940 ± 0.0403 and an ROC-AUC of 0.9449. External fundus validation further demonstrated cross-dataset robustness, achieving 0.9312 Macro F1 and 0.9803 ROC-AUC when trained on HYAMD and tested on AMDNet23. In OCT experiments, the model achieved Macro F1 scores of 0.9790 on MAK1_OCT, 0.9387 on OCTDL, and 0.9989 on the cleaned OCT2017 benchmark test set after MD5 duplicate removal. Ablation results showed that warmup contributed most strongly to stable optimization, while the proposed TPA block provided a smaller but consistent performance gain. Additional statistical analysis across the five HYAMD folds showed that TPA-ConvNeXt achieved comparable performance to the ConvNeXt-Small baseline, with a small numerical accuracy difference that did not reach statistical significance. Grad-CAM visualizations indicated that the model focused on clinically relevant retinal regions, and complexity analysis showed that the full model required 51.82 M parameters and 17.41 GFLOPs, adding only 2.36 M parameters and 0.02 GFLOPs over the ConvNeXt-Small baseline. These findings suggest that TPA-ConvNeXt provides a robust and generalizable framework for retinal image classification across both fundus and OCT modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.